DIRUI INDUSTRIAL CO.,LTD. Dirui Industrial Co.,Ltd. Stock
Equities
300396
CNE100001XS7
Medical Equipment, Supplies & Distribution
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 24.65 CNY | +1.90% |
|
-0.80% | -16.30% |
| Apr. 18 | Dirui Industrial Co.,Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| Mar. 12 | Dirui Industrial Gets Nod to Register 19 Devices | MT |
| Sales 2024 * | 2.31B 319M | Sales 2025 * | 2.98B 411M | Capitalization | 6.72B 928M |
|---|---|---|---|---|---|
| Net income 2024 * | 433M 59.76M | Net income 2025 * | 594M 81.98M | EV / Sales 2024 * | 2.91 x |
| Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 2.25 x |
| P/E ratio 2024 * |
15.6
x | P/E ratio 2025 * |
11.4
x | Employees | 2,092 |
| Yield 2024 * |
1.78% | Yield 2025 * |
2.41% | Free-Float | 44.78% |
More Fundamentals
* Assessed data
More news
| 1 day | +1.90% | ||
| 1 week | -0.80% | ||
| Current month | +11.94% | ||
| 1 month | +10.64% | ||
| 3 months | -10.98% | ||
| 6 months | +0.49% | ||
| Current year | -16.30% |
1 week
23.79
25.20
1 month
21.4025.95
Current year
21.4031.84
1 year
21.0138.51
3 years
13.3538.51
5 years
13.3538.51
10 years
7.8842.78
| Managers | Title | Age | Since |
|---|---|---|---|
Xue Min Wang
CEO | Chief Executive Officer | 52 | 21-09-21 |
Guo Ming Zheng
CEO | Chief Executive Officer | 41 | - |
Jie Song
FOU | Founder | 53 | 92-04-14 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Qing Song
CHM | Chairman | 59 | 20-12-27 |
Jie Song
FOU | Founder | 53 | 92-04-14 |
Ge Yu
BRD | Director/Board Member | 47 | 10-07-25 |
| Date | Price | Change | Volume |
|---|---|---|---|
| 24-04-26 | 24.65 | +1.90% | 5,040,627 |
| 24-04-25 | 24.19 | -1.63% | 3,854,800 |
| 24-04-24 | 24.59 | -1.09% | 5,886,100 |
| 24-04-23 | 24.86 | +2.68% | 6,666,117 |
| 24-04-22 | 24.21 | -2.58% | 9,152,152 |
End-of-day quote Shenzhen S.E., April 25, 2024
More quotes
DIRUI INDUSTRIAL CO.,LTD is a China-based company principally engaged in the research, development, production and sale of medical testing equipment and supporting test paper and reagents. The Company's main products include urine analysis series, urinary composition analysis series, biochemical analysis series and blood cell analysis series. The Company's products are used for routine physical examination and diagnosis of illness. The Company distributes its products in domestic market and to overseas markets.
Calendar
2024-05-10
- Annual General Meeting
Trading Rating
Investor Rating
ESG Refinitiv
Sell
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
24.65
Average target price
-
EPS Revisions
Annual profits - Rate of surprise
| 1st Jan change | Capi. | |
|---|---|---|
| -16.30% | 910M | |
| +0.89% | 12.59B | |
| -10.29% | 7.42B | |
| +1.78% | 5.35B | |
| -1.16% | 4.51B | |
| +5.74% | 4.47B | |
| -50.70% | 3.21B | |
| +12.21% | 2.71B | |
| -16.13% | 1.96B | |
| -11.50% | 1.73B |
- Stock Market
- Equities
- 300396 Stock
